Mergers And Acquisitions

Teva accused of playing games with Mylan's business strategy

Mylan to Teva: 'Stop meddling in our affairs'

By Dan Stanton

Teva has been accused of "playing games" with Mylan by acquiring a 1.35% stake in the generics firm weeks after having a $40bn (EUR36bn) takeover bid snubbed.

AMRI sets sights on acquiring Indian API manufacturer, CEO says

AMRI sets sights on acquiring Indian API manufacturer, CEO says

By Zachary Brennan

Following its three acquisitions over the last year, AMRI is now looking to extend its footprint into India further with the acquisition of a FDA-approved API site, William Marth, president and CEO of AMRI, told attendees at the Barclays Global Healthcare...

DSM to merger pharma business with Patheon

update

DSM plans to merge pharma business with Patheon

By Gareth Macdonald

Royal DSM wants to merge its pharmaceutical products business with Patheon and has signed a deal with the latter's owner, investment group JLL Partners.